ArticleVeterinary sciences2025

Individualized Pooled CRISPR/Cas9 Screenings Identify CDK2 as a Druggable Vulnerability in a Canine Mammary Carcinoma Patient.

Marine Inglebert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.